Table:
begin	end	state
1	30	non-cytoplasmic
31	51	transmembrane
52	62	cytoplasmic
63	82	transmembrane
83	101	non-cytoplasmic
102	127	transmembrane
128	163	cytoplasmic
164	183	transmembrane
184	188	non-cytoplasmic
189	208	transmembrane
209	262	cytoplasmic
263	284	transmembrane
285	298	non-cytoplasmic
299	325	transmembrane
326	336	cytoplasmic
337	355	transmembrane
356	360	non-cytoplasmic
361	382	transmembrane
383	389	cytoplasmic
390	417	transmembrane
418	422	non-cytoplasmic
423	444	transmembrane
445	455	cytoplasmic

Input:
>H281DRAFT_03217 FitnessBrowser__Burk376:H281DRAFT_03217
MPQSTQTRPADVTRQAGASTTASTARRSNARYQILGLLAVGTMINYLDRTVLGIAAPQLT
KELGINAAMMGLLFSVFSWSYVASQIPGGLFLDRFGSKLTYFLSMTFWSLCTLAQGLVHG
IAGLFVFRLGLGVSEAPCFPTNSRVVATWFPQSERAMATGTYTVGEYIGLAFFSPFLFML
MGAFGWRSLFYVVGGVGIVFGVIWWLMYREPRDHPSANQAELDYIEAGGGLTHRHKDGGA
AAAPAKGGFEWRTIGRLLKHRQLTGICLGQFAGNSTLVFFLTWFPTYLATERHMGWLKIG
FFAIMPFIAASIGVMFGGLFSDWLLRRGKSANVARKLPIIAGLLLASTIILANYVESNVA
VIAILSVAFFAQGMAALGWTLVSDIAPEGLLGVTGGIFNFAANLAGIVTPLVVGFIVAAT
GSFVGALVFIGVIALIGALSYIFIVGDIKRIVLVD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server